sr 95531 has been researched along with cholecystokinin in 2 studies
Studies (sr 95531) | Trials (sr 95531) | Recent Studies (post-2010) (sr 95531) | Studies (cholecystokinin) | Trials (cholecystokinin) | Recent Studies (post-2010) (cholecystokinin) |
---|---|---|---|---|---|
610 | 0 | 209 | 10,914 | 466 | 1,074 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Herzig, KH; Hoepfner, M; Jansen, A; Riecken, EO; ScherĂ¼bl, H | 1 |
Andresen, MC; Appleyard, SM; Kobayashi, K; Low, MJ; Marks, D; Okano, H | 1 |
2 other study(ies) available for sr 95531 and cholecystokinin
Article | Year |
---|---|
GABA(C) receptors in neuroendocrine gut cells: a new GABA-binding site in the gut.
Topics: Acrylates; Animals; Bicuculline; Calcium; Cholecystokinin; Cytarabine; GABA Antagonists; gamma-Aminobutyric Acid; Gene Expression; Immunohistochemistry; Intestinal Neoplasms; Kinetics; Mice; Mice, Transgenic; Neuroendocrine Tumors; Organophosphorus Compounds; Pyridazines; Receptors, GABA; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured | 2000 |
Visceral afferents directly activate catecholamine neurons in the solitary tract nucleus.
Topics: 4-Aminopyridine; Afferent Pathways; Analysis of Variance; Animals; Catecholamines; Cholecystokinin; Dose-Response Relationship, Radiation; Electric Stimulation; Excitatory Amino Acid Antagonists; Green Fluorescent Proteins; In Vitro Techniques; Membrane Potentials; Mice; Mice, Transgenic; Neurons; Patch-Clamp Techniques; Potassium Channel Blockers; Pyridazines; Quinoxalines; Solitary Nucleus; Tyrosine 3-Monooxygenase | 2007 |